resistance to immunotherapy in multiple myeloma: mechanisms & monitoring
Published 1 year ago • 107 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
3:58
mechanisms of resistance in multiple myeloma treatments
-
1:41
understanding mechanisms of resistance to immunotherapies in myeloma
-
2:10
genomic factors underlying resistance to immunotherapy in newly diagnosed multiple myeloma
-
3:09
an overview of the toxicities associated with immunotherapy in multiple myeloma
-
1:39
understanding mechanisms of resistance in myeloma
-
1:29
managing toxicities associated with immunotherapy in multiple myeloma
-
3:37
tumor-intrinsic resistance to immunotherapies in multiple myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
1:57
what is the survival rate for multiple myeloma?
-
4:04
the future of myeloma treatment and the possibility of cure
-
1:59
the rapid evolution of myeloma research & the importance of improving drug accessibility
-
2:26
the role of the bone marrow immune microenvironment on response to treatment in multiple myeloma
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
3:11
sequencing immunotherapies in multiple myeloma
-
3:26
genomic determinants of resistance in patients with ndmm treated with targeted immunotherapy
-
5:06
advances in immunotherapy for multiple myeloma and future outlooks
-
3:09
immunotherapy in myeloma - where are we?
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
3:04
how to generate an anticancer immune response in multiple myeloma
-
0:53
discovering immunotherapy resistance mechanisms using single-cell technologies